CellVoyant and HyQure Announce Strategic Partnership to Advance AI-Driven Biologics Testing and Quality Control
BASEL, SWITZERLAND and SHANGHAI/ZHEJIANG, CHINA and BRISTOL, UK — 15 JULY 2026 — CellVoyant, a pioneer in AI foundation models for live-cell analytics and predictive cell biology, and HyQure, a leading CRO specialising in viral safety testing, biologics quality control and advanced analytical services, today announced a strategic partnership to explore the application of artificial intelligence in biologics testing and quality assessment.
The collaboration brings together CellVoyant’s expertise in AI-powered label-free cell analysis with HyQure’s extensive experience in biologics testing and analytical services. Together, the companies aim to develop innovative approaches that enhance the efficiency, consistency, and scalability of quality control workflows across the biopharmaceutical industry.
Through the partnership, the companies will collaborate on the development and validation of AI-enabled analytical solutions designed to support biologics testing and cell characterisation. The collaboration will also establish a foundation for future innovation opportunities in advanced cell analytics and quality assessment technologies.
“Biologics development increasingly relies on high-quality, data-driven decision making,” said Rafael E. Carazo Salas, Founder and CEO of CellVoyant. “By combining our AI capabilities with HyQure’s deep expertise in biologics testing, we aim to accelerate the adoption of more predictive, scalable and standardised analytical approaches across the industry.”
“HyQure is committed to bringing innovative technologies to our clients,” said Shirley Zhu, CEO of HyQure. “This partnership with CellVoyant provides an exciting opportunity to explore how advanced AI can support the future of biologics testing and quality control.”
The companies also plan to collaborate on joint scientific and commercial activities to promote the adoption of AI-enabled analytics within the biopharmaceutical sector.
By combining complementary expertise in artificial intelligence and biologics testing, CellVoyant and HyQure aim to help advance the next generation of data-driven quality control solutions for biologics and advanced therapies.
About CellVoyant
CellVoyant has pioneered AI foundation models enabling non-destructive, real-time cell analysis, prediction and optimisation across cell-based therapeutics development, manufacturing workflows and advanced life sciences applications.
About HyQure
HyQure is a global CRO specialising in viral safety testing, biologics quality control and advanced analytical services for the biopharmaceutical industry, supporting clients across biologics, vaccine, and cell and gene therapy development programmes.
Media Contacts
CellVoyant: info@cellvoyant.com
HyQure: service@hyqure.com